First Trust NYSE Arca Biotechnology Index Fund
109 hedge funds and large institutions have $281M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 28 closing their positions.
72% more call options, than puts
Call options by funds: $1.54M | Put options by funds: $900K
1.16% more ownership
Funds ownership: 33.81% → 34.98% (+1.2%)
0% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 31
4% less capital invested
Capital invested by funds: $292M → $281M (-$10.4M)
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
2% less funds holding
Funds holding: 111 → 109 (-2)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$25.1M |
| 2 |
FEG
Financial Enhancement Group
Anderson,
Indiana
|
+$4.48M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$2.33M |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
+$2.05M |
| 5 |
MWM
MinichMacGregor Wealth Management
Saratoga Springs,
New York
|
+$1.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$3.05M |
| 2 |
TH
Timber Hill
Greenwich,
Connecticut
|
-$2.8M |
| 3 |
SG
Somerset Group
Wayzata,
Minnesota
|
-$2.56M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.1M |
| 5 |
Nomura Asset Management
Tokyo,
Japan
|
-$1.83M |
FBT Hedge Fund Activity: Q4 2016 in Review
109 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2016, worth a combined $281M — down 3.6% from $292M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of FBT and 27 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 31 added.
The largest buyer was Morgan Stanley, adding an estimated $25.1M. The largest seller was Bank of America, cutting an estimated $3.05M.
- 109 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2016, down from 111 in Q3 2016.
- Funds reported $281M of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2016, down 3.6% quarter-over-quarter.
- 27 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2016 and 28 closed out, a net change of -1 holder.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2016 was Morgan Stanley, an estimated $25.1M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2016 was Bank of America, an estimated $3.05M sold.
Based on aggregated 13F filings for Q4 2016.